Glutathione Metabolism: An Achilles' Heel of ARID1A-Deficient Tumors.
MetadataShow full item record
In this issue of Cancer Cell, Ogiwara et al. describe a novel link between the epigenetic regulator ARID1A and glutathione metabolism in cancer that is mediated by regulation of the cystine/glutamate transporter XCT. This work reveals that synthesis of reduced glutathione is a metabolic dependency of cancers with ARID1A-inactivating mutations.
Amino Acid Transport System y+
Target Evaluation and Molecular Therapeutics
License start date
Cancer cell, 2019, 35 (2), pp. 161 - 163